The impact of COVID-19 disease on platelets and coagulation
GD Wool, JL Miller - Pathobiology, 2021 - karger.com
Abstract Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some
patients develop a severe proinflammatory state which can be associated with a unique …
patients develop a severe proinflammatory state which can be associated with a unique …
The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications
JD McFadyen, H Stevens, K Peter - Circulation research, 2020 - Am Heart Assoc
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …
and the ensuing global pandemic has presented a health emergency of unprecedented …
Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study
D Wichmann, JP Sperhake… - Annals of internal …, 2020 - acpjournals.org
Background: The new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), has caused more than 210 000 deaths worldwide. However, little is known about …
CoV-2), has caused more than 210 000 deaths worldwide. However, little is known about …
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
COVID-19 affects millions of patients worldwide, with clinical presentation ranging from
isolated thrombosis to acute respiratory distress syndrome (ARDS) requiring ventilator …
isolated thrombosis to acute respiratory distress syndrome (ARDS) requiring ventilator …
Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among …
Importance Thrombotic events are commonly reported in critically ill patients with COVID-19.
Limited data exist to guide the intensity of antithrombotic prophylaxis. Objective To evaluate …
Limited data exist to guide the intensity of antithrombotic prophylaxis. Objective To evaluate …
Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with …
AC Spyropoulos, M Goldin, D Giannis… - JAMA internal …, 2021 - jamanetwork.com
Importance Hospitalized patients with COVID-19 are at risk for venous and arterial
thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is …
thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is …
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …
2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
Review of cardiac involvement in multisystem inflammatory syndrome in children
T Alsaied, AH Tremoulet, JC Burns, A Saidi, A Dionne… - Circulation, 2021 - Am Heart Assoc
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) with substantial cardiovascular …
respiratory syndrome coronavirus 2 (SARS-CoV-2) with substantial cardiovascular …
COVID-19 and venous thromboembolism: a meta-analysis of literature studies
A Di Minno, P Ambrosino, I Calcaterra… - … in thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations,
leading in some cases to a critical condition with poor long-term outcomes and residual …
leading in some cases to a critical condition with poor long-term outcomes and residual …